Latest News

We are excited to share our new collaborative paper, A systematic review and analysis of the use of polygenic scores in pharmacogenomics, which was published in Clinical Pharamcology and Therapeutics. This article iss the first to comprehensively assess the use of polygenic scores in pharmacogenomics and show the clinical relevance of these scores for drug-related clinical outcomes.

Welcome, Abdoulaye Diarra, who is joining the team as a full-time research technician! Abdoulaye recently completed their M.Sc. in Immunology (2020) from the University of Manitoba (Ghia lab). We look forward to working with them!

The Summer of 2021 has flown by! We celebrated the progress of our undergrad researchers by having them present brief research presentations! Farewell Gabi and Claudia, we wish you the best for the future!

Welcome to our first graduate student, Alana Slike! Alana completed their B.Sc. (Hons.) in Neuroscience at University of Winnipeg and performed her thesis research work related to aging and Alzheimer’s disease in the Albensi lab at the University of Manitoba.

Galen was awarded a Future Leaders in Canadian Brain Research grant: Investigation of DNA damage response as a genomic modifier in Rett syndrome Funded by Brain Canada ($100,000). This work was one of 20 projects funded and will allow the lab to investigate genetic modifiers using human stem cells, CRISPR gene editing and genomics!

Galen was awarded a Tier 2 Canada Research Chair in Neurogenomics ($600,000)! This postion is federally funded through NSERC and will allow the lab to investigate fundamental processes in the brain using computational and functional genomic approaches.

The group was awarded our first grant! We are thankful for the support of the Health Sciences Centre Foundation (HSCF), who funded our General Operating Grant, Fine-mapping of neurodegenerative disorder genomic risk loci for the prioritization of novel drug targets ($70,000).